MedPath

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Phase 3
Active, not recruiting
Conditions
Diabetic Macular Edema
Neovascular Age-Related Macular Degeneration
Interventions
Registration Number
NCT06491914
Lead Sponsor
Regeneron Pharmaceuticals
Brief Summary

This study is researching aflibercept high dose (HD), referred to as "study drug", with an experimental dosing regimen. The study is focused on participants with nAMD and DME that have been previously treated with anti-vascular endothelial growth factor (anti-VEGF) medications.

The aim of the study is to see how safe and effective aflibercept HD injections are when given as frequently as every 4 weeks. The study is also looking at what side effects may happen from taking the study drug.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1118
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Aflibercept 8 mgAflibercept 8 mgParticipants previously treated with anti-vascular endothelial growth factor (anti-VEGF) medications
Primary Outcome Measures
NameTimeMethod
Occurrence of serious TEAEsThrough week 24
Occurrence of treatment-emergent adverse events (TEAEs)Through week 24
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (55)

Win Retina - Arcadia

🇺🇸

Arcadia, California, United States

California Retina Consultants

🇺🇸

Bakersfield, California, United States

Retina Specialists of Beverly Hills

🇺🇸

Beverly Hills, California, United States

Salehi Retina Institute dba Retina Associates of Southern California

🇺🇸

Huntington Beach, California, United States

South Coast Retina Center

🇺🇸

Long Beach, California, United States

California Eye Specialists Medical Group, Inc.

🇺🇸

Pasadena, California, United States

Retina Consultants of Southern California

🇺🇸

Redlands, California, United States

Vrmg Inc

🇺🇸

Sacramento, California, United States

Retina Consultants of Southern Colorado

🇺🇸

Colorado Springs, Colorado, United States

Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute

🇺🇸

Longmont, Colorado, United States

Scroll for more (45 remaining)
Win Retina - Arcadia
🇺🇸Arcadia, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.